Evidence map›Paper›PMID 42559023›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2026

Quantitative

Yoichi Otomi, Hideki Otsuka, Ryosuke Kasai, Tamaki Otani, Noritake Matsuda, Takayuki Ise, Shusuke Yagi, Masataka Sata, Takayoshi Shinya, Masafumi Harada

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoichi OtomiDepartment of Radiology, Tokushima University Hospital, Tokushima, Japan.
Hideki OtsukaDepartment of Medical Imaging/Nuclear Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Ryosuke KasaiDepartment of Medical Imaging/Nuclear Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Tamaki OtaniAdvance Radiation Research, Education and Management Center, Tokushima University, Tokushima, Japan.
Noritake MatsudaDepartment of Radiological Technology, Tokushima University Hospital, Tokushima, Japan.
Takayuki IseDepartment of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan.
Shusuke YagiDepartment of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan.
Masataka SataDepartment of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan.
Takayoshi ShinyaDepartment of Radiology, Tokushima University Hospital, Tokushima, Japan.
Masafumi HaradaDepartment of Radiology, Tokushima University Hospital, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly recognized as a cause of heart failure in elderly patients. Noninvasive diagnosis with technetium-99m pyrophosphate (

Indexed as

99mTc-Pyrophosphate SPECT/CTQuantitative imaging Transthyretin amyloidosisTafamidis

Identifiers

PMID42559023
PMCPMC13438365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.